Cosentyx - NDC Database
4 records found
Page:
0078-0639 Jan 21, 2015
Cosentyx 150 mg/ml Subcutaneous Injection by Novartis Pharmaceuticals Corporation
Cosentyx 150 mg/ml Subcutaneous Injection by Novartis Pharmaceuticals Corporation
0078-1056 Jan 21, 2015
Cosentyx 75 mg/.5ml Subcutaneous Injection by Novartis Pharmaceuticals Corporation
Cosentyx 75 mg/.5ml Subcutaneous Injection by Novartis Pharmaceuticals Corporation
0078-1070 Jan 21, 2015
Cosentyx 300 mg/2ml Subcutaneous Injection by Novartis Pharmaceuticals Corporation
Cosentyx 300 mg/2ml Subcutaneous Injection by Novartis Pharmaceuticals Corporation
0078-1168 Oct 06, 2023
Cosentyx 25 mg/ml Intravenous Injection, Solution, Concentrate by Novartis Pharmaceuticals Corporation
Cosentyx 25 mg/ml Intravenous Injection, Solution, Concentrate by Novartis Pharmaceuticals Corporation
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.